Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Legal Life Plans, Inc.
SIC 8000 · Services-Health Services
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Legal Life Plans, Inc.
SIC 8000 · Services-Health Services
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Legal Life Plans, Inc.
SIC 8000 · Services-Health Services
Notes
Support
about
terms
Legal Life Plans, Inc.
CIK:
0000876367
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v2.4.0.8
NOTE 14 - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Restatement adjustments on the statement of operations (Details) (USD $)
12 Months Ended
May 31, 2013
May 31, 2012
Net revenues
$ 0
$ 0
Operating expenses:
Professional fees
61,173
62,114
General and administrative
22,385
24,250
Total operating expenses
83,558
86,364
Operating loss
(83,558)
(86,364)
Other income (expense)
Interest income
(1,410)
(4,540)
Interest expense
(12,945)
(10,220)
Total other income (expense)
11,535
5,680
Net loss before income taxes
(95,093)
(92,044)
Income tax expense
0
0
Net loss
(95,093)
(92,044)
Loss per share-basic and diluted
$ (0.55)
$ (0.54)
As previously reported
Net revenues
0
Operating expenses:
Professional fees
62,114
General and administrative
24,250
Total operating expenses
86,364
Operating loss
(86,364)
Other income (expense)
Interest income
4,540
Interest expense
(11,456)
Total other income (expense)
(6,916)
Net loss before income taxes
(93,280)
Income tax expense
0
Net loss
(93,280)
Loss per share-basic and diluted
$ (0.54)
Restatement Adjustments
Net revenues
0
Operating expenses:
Professional fees
0
General and administrative
0
Total operating expenses
0
Operating loss
0
Other income (expense)
Interest income
0
Total other income (expense)
1,236
Net loss before income taxes
1,236
Income tax expense
0
Net loss
1,236
Loss per share-basic and diluted
$ 0
Restatement Adjustment (4)
Other income (expense)
Interest expense
11,456
Restatement Adjustments
To reverse interest expense accrued on the notes payable to an individual for the year ended May 31, 2012 (see (3) above).
Restatement Adjustment (5)
Other income (expense)
Interest expense
(10,220)
Restatement Adjustments
To accrue interest expense on the liabilities restored (see (1) above) for the year ended May 31, 2012.
As Restated
Net revenues
0
Operating expenses:
Professional fees
62,114
General and administrative
24,250
Total operating expenses
86,364
Operating loss
(86,364)
Other income (expense)
Interest income
4,540
Interest expense
(10,220)
Total other income (expense)
(5,680)
Net loss before income taxes
(92,044)
Income tax expense
0
Net loss
$ (92,044)
Loss per share-basic and diluted
$ (0.54)
v2.4.0.8
Condensed Statements of Cash Flows (USD $)
12 Months Ended
May 31, 2013
May 31, 2012
Cash flows from operating activities:
Net loss
$ (95,093)
$ (92,044)
Adjustments to reconcile net loss to net cash used inoperating activities
Due from related party
(7,540)
0
Interest receivable
(1,409)
(4,540)
Accounts payable and accrued expenses
38,007
56,387
Obligation for shares to be issued
14,400
125,000
Due to related party
17,550
18,700
Accrued interest on notes payable
10,780
8,125
Net cash (provided by) used in operating activities
(23,305)
(8,372)
Cash flows from investing activities:
Funding of notes receivable
(16,000)
0
Collection of notes receivable
9,200
3,600
Net cash provided by (used in) investing activities
(6,800)
3,600
Cash flows from financing activities:
Proceeds from notes payable
30,000
0
Net cash provided by financing activities
30,000
0
Net decrease in cash and cash equivalents
(105)
(4,772)
Cash and cash equivalents, beginning of year
105
4,877
Cash and cash equivalents, end of year
0
105
Supplemental disclosures of cash flow information:
Cash paid for interest
0
0
Cash paid for income taxes
0
0
Non-cash operating and investing activities:
Settlement of notes receivable and related accrued interest through extinguishment of liabilities (net set-off)
72,277
0
Satisfaction of settlement agreement (recorded as a reduction of other accrued expenses payable) through direct payments to plaintiff from funds provided by the obligation of shares to be issued
$ 0
$ 120,000
v2.4.0.8
Balance Sheets (USD $)
May 31, 2013
May 31, 2012
Current assets
Cash
$ 0
$ 105
Due from related party
7,540
0
Total current assets
7,540
105
Other assets
Notes receivable
0
53,900
Interest receivable
0
10,168
Total other assets
0
64,068
Total assets
7,540
64,173
Current liabilities
Accounts payable and accrued expenses
155,327
189,597
Due to related parties
58,750
41,200
Obligations for shares to be issued
194,400
180,000
Notes payable, including accrued interest of $40,092 and $31,967 as of May 31, 2013 and 2012, respectively
140,092
131,967
Note payable to related party, including accrued interest of $2,655 and $0 as of May 31, 2013 and 2012, respectively
32,655
0
Total current liabilities and total liabilities
581,224
542,764
Preferred stock, $0.001 par value; 20,000,000 shares authorized:
Common stock, $0.001 par value; 500,000,000 shares authorized, 171,419 and 171,419 shares issued and outstanding, respectively
171
171
Additional paid-in capital
3,545,931
3,545,931
Accumulated deficit
(4,119,786)
(4,024,693)
Total stockholders' deficit
(573,684)
(478,591)
Total liabilities and stockholders' deficit
7,540
64,173
Series A Preferred Stock
Preferred stock, $0.001 par value; 20,000,000 shares authorized:
Series A Preferred Stock, 200 and 200 shares issued and outstanding, respectively
0
0
Series B Preferred Stock
Preferred stock, $0.001 par value; 20,000,000 shares authorized:
Series B Preferred Stock, 0 and 0 shares issued and outstanding, respectively
$ 0
$ 0